Capstone director Michael Toporek acquires common shares worth $167,000
CAPS•Toporek buys 41,750 Capstone shares
Capstone Therapeutics director Michael Toporek bought 41,750 common shares in an open-market purchase at $4 per share.
Toporek’s direct stake rose to 41,750 shares following the transaction.




